Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nano-TAB v0.5 Specification Development Effort Weekly Meeting June 8, 2010.

Published byDeborah Berry Modified over 8 years ago

Similar presentations

Presentation on theme: "Nano-TAB v0.5 Specification Development Effort Weekly Meeting June 8, 2010."— Presentation transcript:

1 nano-TAB v0.5 Specification Development Effort Weekly Meeting June 8, 2010

2 Agenda Review NTP Study and Example Files Follow-up on Actions Review Project Status and Discuss Next Steps

3 NTP Fullerene-C60 Study

4 Toxicology/Carcinogenicity Studies

5 13-Week Toxicity Study Protocol

6 DRAFT Investigation and Studies (1 of 2) INVESTIGATION TITLE: 90 Day Toxicity Study for Nanoscale material (Fullerene-C60) DESCRIPTION: Obtain toxicological data and determine the treatments for each strain and species to be used in the 2-year toxicology/carcinogenesis study STUDY #1: TITLE: Standard Toxicology and Carcinogenesis Studies DESCRIPTION: Analysis of rats and mice of both sexes exposed to concentrations of fullerene-C60 for a period of 13 weeks. DESIGN: exposure; time course; compound based treatment FACTORS: duration of exposure; dose; compound; strain; sex ASSAYS: ASSAY MEASUREMENTS: body weight ASSAY TECHNOLOGY TYPE: PROTOCOLS: PROTOCOL NAME: 13-Week Toxicity Study PROTOCOL PARAMETERS: duration of exposure; compound; dose; route of exposure; strain; sex; diet; cage group; sacrifice method

7 DRAFT Investigation and Studies (2 of 2) STUDY #2: TITLE: Genetic Toxicology Study DESCRIPTION: Analysis of the frequency of micronucleated erythrocytes in rats and mice of both sexes exposed to concentrations of fullerene-C60 for a period of 13 week as an in vivo measure of genotoxic potential DESIGN: exposure; time course; compound based treatment FACTORS: duration of exposure; dose; compound; strain; sex ASSAYS: ASSAY MEASUREMENTS: total MN cells, percent PCD, MC cells per 1000 ASSAY TECHNOLOGY TYPE: PROTOCOLS: PROTOCOL NAME: 13-Week Toxicity Study PROTOCOL PARAMETERS: duration of exposure; compound; dose; route of exposure; strain; sex; diet; cage group; sacrifice method

8 DRAFT NTP Investigation File (1 of 3)

9 DRAFT NTP Investigation File (2 of 3)

10 DRAFT NTP Investigation File (3 of 3)

11 Study Samples Nanomaterial SOURCE: 99685-96-8 SAMPLE NAME: 99685-96-8 MATERIAL TYPE: fullerene CHARACTERISTICS: description: fullerene C-60 number of carbons: 60 Diameter (?): 1 micron; 50 nanometers Biological Material SOURCE: B6C37.1..1000+; Wistar.1.1000+; (Animal ID 1..1000+) SAMPLE NAME: B6C37.1..1000+; Wistar.1.1000+; (Animal ID 1..1000+) MATERIAL TYPE: whole organism CHARACTERISTICS organism: mice; rats strain: B6C3F1; Wistar Han sex: male; female PROTOCOL REF PARAMETER VALUE compound: 99685-96-8 duration of exposure: 90 days FACTOR VALUE dose: vehicle control; 0.5; 2.0 unit: mg/m3

12 Study-Sample Files - Material

13 Study-Sample Files - Animals (1 of 2)

14 Study-Sample Files- Animals (2 of 2)

15 Standard Toxicology & Carcinogenesis Studies

16 Study Search Criteria

17 Body Weight Results

18 Body Weight Assay File (1 of 2)

19 Body Weight Assay File (2 of 2)

20 Micronucleus Study

21 Micronucleus Study Search

22 Summary Results

23 Detailed Results

24 Individual Animal Data

25 Micronucleus Assay File TBD

26 Agenda Review NTP Study and Example Files Follow-up on Actions Review Project Status and Discuss Next Steps

27 Follow-up on Actions ActionAssigned To Draft example files for the NTP dataSharon Gaheen Identify top ten (10) nanotechnology assays leveraging ASTM protocolsStacey Harper Marty Fritts Continue to update nano-TAB filesSharon Gaheen Stacey Harper Continue to update the NPO in support of nano-TAB termsDennis Thomas

28 Agenda Review NTP Study and Example Files Follow-up on Actions Review Project Status and Discuss Next Steps

29 Project Status

30 Next Steps Continue review/update of nano-TAB files Update files based on feedback from the 6/11 ISA-TAB discussion Create assay files for prioritized ASTM assays Continue drafting assays files for NTP nanomaterial studies and review with the NTP Continue collaborations with the ISA-TAB organization Schedule next meeting for early June (est. June 11) Obtain overview of ISA-TAB tools Continue updating NPO in support of nano-TAB ontology needs Begin drafting nano-TAB specification (https://gforge.nci.nih.gov/docman/view.php/69/21873/nano-TAB_v0.5_specification.doc)https://gforge.nci.nih.gov/docman/view.php/69/21873/nano-TAB_v0.5_specification.doc Specification Summary – Sharon Gaheen Section 1: Introduction – Stacey Harper Section 2: nano-TAB Structure – Sharon Gaheen, Stacey Harper, and Raul Cachua (Structures) Section 3: Relationships to Standards – Dennis Thomas, Nathan Baker (ASTM) Section 4: nano-TAB Details - Sharon Gaheen, Stacey Harper, Dennis Thomas, and Raul Cachua (Structures) Section 5: References – TBD Document Review – All Team Members Review/update nano-TAB timeline Next meeting: Tuesday, June 15, 11:00-12:00

31 References Nano-TAB http://gforge.nci.nih.gov/docman/index.php?group_id=69&selected_doc_group_id= 5653&language_id=1http://gforge.nci.nih.gov/docman/index.php?group_id=69&selected_doc_group_id= 5653&language_id=1 LS DAM Nano Subdomain https://gforge.nci.nih.gov/plugins/scmsvn/viewcvs.php/*checkout*/requirements/LS DAM%20R1_2.EAP?root=lsdamhttps://gforge.nci.nih.gov/plugins/scmsvn/viewcvs.php/*checkout*/requirements/LS DAM%20R1_2.EAP?root=lsdam caBIG ICR Nano Data Standards Document http://sites.google.com/site/cabignanowg/data-sharing-and-nanotechnology- standards/data-sharing-standardshttp://sites.google.com/site/cabignanowg/data-sharing-and-nanotechnology- standards/data-sharing-standards MAGE-TAB http://www.mged.org/mage-tab/MAGE-TABv1.0.pdf http://www.mged.org/mage-tab/spec1.0.html ISA-TAB http://isatab.sourceforge.net/

Download ppt "Nano-TAB v0.5 Specification Development Effort Weekly Meeting June 8, 2010."

Similar presentations

Overview of the Keys to Successful Commercialization Gerald J. Siuta, Ph.D. President Siuta Consulting, Inc. Tucson, Arizona October 18, 2001.

Overview of the Keys to Successful Commercialization Gerald J. Siuta, Ph.D. President Siuta Consulting, Inc. Tucson, Arizona October 18, 2001.
IWGT Group 4 Improving in vivo genotoxicity testing- the link to standard toxicity testing Summary of discussion items, conclusions and recommendations.

IWGT Group 4 Improving in vivo genotoxicity testing- the link to standard toxicity testing Summary of discussion items, conclusions and recommendations.
FCMAT Response & Preparation: Process Outline 2006-07 October 25, 2006.

FCMAT Response & Preparation: Process Outline October 25, 2006.
Preclinical Drug Development Miss Sirikan Nawapan.

Preclinical Drug Development Miss Sirikan Nawapan.
Workshop Highlights Relevant to Nano WG High Quality Data Sets - There is a critical need for high quality data sets as input to predictive models. This.

Workshop Highlights Relevant to Nano WG High Quality Data Sets - There is a critical need for high quality data sets as input to predictive models. This.
Evaluation of a potential mutagenic MOA based on analysis of the weight of evidence and using the modified Hill criteria Martha M. Moore, Ph.D. Director,

Evaluation of a potential mutagenic MOA based on analysis of the weight of evidence and using the modified Hill criteria Martha M. Moore, Ph.D. Director,
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Working with FDA: Biological Products and Clinical Development IND Case Studies.

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Working with FDA: Biological Products and Clinical Development IND Case Studies.
Informatics and standards for nanomedicine technology Dennis G. Thomas, Pacific Northwest National Lab Alan Chappell, Pacific Northwest National Lab Elaine.

Informatics and standards for nanomedicine technology Dennis G. Thomas, Pacific Northwest National Lab Alan Chappell, Pacific Northwest National Lab Elaine.
1 Nano WG Activities for Current Period – NPO Related Establish formal processes incorporating JIRA tracker for Nanoparticle Ontology (NPO) governance.

1 Nano WG Activities for Current Period – NPO Related Establish formal processes incorporating JIRA tracker for Nanoparticle Ontology (NPO) governance.
APA Writing Style American Psychological Association. (2001). Publication manual of the American Psychological Association (5 th ed.). Washington, DC:

APA Writing Style American Psychological Association. (2001). Publication manual of the American Psychological Association (5 th ed.). Washington, DC:
Geant4 Documentation and User Support Geant4 Users Workshop 18-22 February 2002 Dennis Wright (SLAC)

Geant4 Documentation and User Support Geant4 Users Workshop February 2002 Dennis Wright (SLAC)
Overview Nano WG The National Cancer Institute (NCI) caBIG® Nanotechnology Working Group (Nano WG) Jessica M. Adamick 1, Nathan A. Baker 2, Alan R. Chappell.

Overview Nano WG The National Cancer Institute (NCI) caBIG® Nanotechnology Working Group (Nano WG) Jessica M. Adamick 1, Nathan A. Baker 2, Alan R. Chappell.
Guidance for Industry M4S: The CTD-Safety

Guidance for Industry M4S: The CTD-Safety
ILSI Risk Science Institute Acrylamide Toxicity: Research to Address Key Data Gaps Presented by Dr. Stephen S. Olin ILSI Risk Science Institute.

ILSI Risk Science Institute Acrylamide Toxicity: Research to Address Key Data Gaps Presented by Dr. Stephen S. Olin ILSI Risk Science Institute.
Application of Toxicology Databases in Drug Development (Estimating potential toxicity) Joseph F. Contrera, Ph.D. Director, Regulatory Research and Analysis.

Application of Toxicology Databases in Drug Development (Estimating potential toxicity) Joseph F. Contrera, Ph.D. Director, Regulatory Research and Analysis.
Writing the First Draft ENGL 3100 Dr. Shelley Thomas Based on Dr. Brenda Orbell’s original presentation.

Writing the First Draft ENGL 3100 Dr. Shelley Thomas Based on Dr. Brenda Orbell’s original presentation.
Assays from the EU's Science Committee on Consumer Safety guidance document and from the EPA's conditional approval for HEIQ AG 20S Fred Klaessig, September.

Assays from the EU's Science Committee on Consumer Safety guidance document and from the EPA's conditional approval for HEIQ AG 20S Fred Klaessig, September.
CaNanoLab Data Curation Overview NCI Nano WG June 6, 2013.

CaNanoLab Data Curation Overview NCI Nano WG June 6, 2013.
Nanomaterial Registry: Minimal Information Standards for Well-Characterized Nanomaterials in Environmental and Biological Studies Michele L. Ostraat April.

Nanomaterial Registry: Minimal Information Standards for Well-Characterized Nanomaterials in Environmental and Biological Studies Michele L. Ostraat April.
1 st (RSBI) ISA-Tab Workshop – Scope and Outcome  Tackle today's need for exchange of multi-omics experiments Evaluate the ISA-TAB straw-man (incomplete)

1 st (RSBI) ISA-Tab Workshop – Scope and Outcome  Tackle today's need for exchange of multi-omics experiments Evaluate the ISA-TAB straw-man (incomplete)

Similar presentations

Ads by Google